Order online Acomplia Rimonabant
2008
10
May
Anti-Obesity Treatments 2007-2012PharmiWeb.com (press release), UK -May 9, 2008The US health panel's rejection of Sanofi-Aventis' obesity drug Zimulti however has cast a shadow over other experimental products in the same class while …
More: continued here
2008
9
May
Weight-loss drugs may harm developing brain: studyABS CBN News, Philippines -May 8, 2008Sanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
9
May
Weight Loss drugs may ruin children's brainMacedonia, Canada -May 7, 2008Sanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
8
May
Weight-loss drugs may harm developing brain: studyReuters -23 hours agoSanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
8
May
Weight-loss drugs may harm developing brain -studyReuters India, India -23 hours agoPA: Quote, Profile, Research) weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new …
More: continued here
2008
8
May
Weight-loss drugs may harm developing brain: studyNational Post, Canada -23 hours agoSanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
8
May
Weight-loss drugs may harm developing brain: studyReuters UK, UK -23 hours agoSanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
8
May
Weight-loss drugs may harm developing brain: studyCanada.com, Canada -23 hours agoSanofi-Aventis' weight-loss pill rimonabant, also known as Zimulti and sold under the brand name Acomplia in Europe, is the first in this new class of drugs …
More: continued here
2008
30
Apr
Sanofi Q1 figures beat forecastsBusiness Spectator, Australia -13 hours agoInvestors are wary about its ability to get new medicines to market following US rejection of its obesity pill Acomplia, or Zimulti, last year. …
More: continued here
2008
30
Apr
Sanofi Q1 beats forecasts but new drug fails testEarthtimes (press release), UK -14 hours agoInvestors are wary about its ability to get new medicines to market following US rejection of its obesity pill Acomplia, or Zimulti, last year. …
More: continued here